访视间血压变异性与冠状动脉粥样斑块进展及临床结局
该研究为7项随机临床试验的事后患者水平分析,纳入3912例接受系列血管内超声检查的冠心病患者。结果显示,收缩期血压变异性越大,冠脉斑块体积百分比进展越显著,且累积主要不良心血管事件随收缩期血压变异性四分位升高呈阶梯式增加;舒张期血压变异性与脉压变异性未见同等关联。
要点
- 收缩期血压变异性与冠脉斑块进展独立相关。
- 收缩期血压变异性越高,主要不良心血管事件累积发生率越高。
- 舒张期血压变异性和脉压变异性未见同等阶梯关联。
核心结论
- 较大的血压变异性,尤其是收缩期血压变异性,与冠状动脉粥样斑块进展和不良临床结局显著相关。
- 维持血压稳定可能对进一步改善冠心病患者结局具有重要意义。
研究设计与样本
- 研究为7项随机临床试验的事后患者水平分析,纳入2004至2016年间3912例冠心病患者。
- 患者来自多中心、国际性初级和三级诊疗中心,均接受系列血管内超声检查并处于多种药物治疗背景下。
- 访视间血压变异性采用3、6、12、18和24个月内的个体内标准差测量。
- 主要结局为斑块体积百分比进展和主要不良心血管事件(死亡、心肌梗死、卒中、急性冠脉综合征紧急血运重建、不稳定心绞痛住院)。
- 数据分析时间为2017年11月至2019年3月。
临床怎么用
- 在冠心病患者管理中,除关注平均血压水平外,还应重视访视间收缩期血压的稳定性。
- 收缩期血压变异性较高的冠心病患者可能需更密切的随访和血压管理优化。
局限性
- 研究为随机临床试验的事后分析,结果可能受原始试验设计和人群特征影响。
- 研究对象以白人为主(3633/3912,93%),女性占28%,外推至其他人群需谨慎。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Visit-to-visit blood pressure variability (BPV) is associated with cardiovascular events, but mechanisms and therapeutic implications underlying this association are not well understood. OBJECTIVE: To examine the association of intraindividual BPV, coronary atheroma progression, and clinical outcomes using serial intravascular ultrasonography. DESIGN, SETTING, AND PARTICIPANTS: Post hoc patient-level analysis of 7 randomized clinical trials conducted from 2004 to 2016 involving 3912 patients in multicenter, international, clinic-based primary and tertiary care centers. Adult patients with coronary artery disease who underwent serial intravascular ultrasonography in the setting of a range of medical therapies were included. Data were analyzed between November 2017 and March 2019. EXPOSURES: Visit-to-visit BPV measured using intraindividual standard deviation over 3, 6, 12, 18, and 24 months. MAIN OUTCOMES AND MEASURES: Percent atheroma volume (PAV) progression and major adverse cardiovascular events (defined as death, myocardial infarction, stroke, urgent revascularization for acute coronary syndrome, and hospitalization for unstable angina). RESULTS: Of 3912 patients, the mean (SD) age was 58 (9) years, 1093 (28%) were women, and 3633 (93%) were white . Continuous change in PAV was significantly associated with systolic BPV (β, .049; 95% CI, 0.021-0.078; P = .001), diastolic BPV (β, .031; 95% CI, 0.002-0.059; P = .03), and pulse pressure variability (β, .036; 95% CI, 0.006-0.067; P = .02), without a signal for differential effect greater than or less than a mean BP of 140/90 mm Hg. The PAV progression as a binary outcome was significantly associated with systolic BPV (odds ratio, 1.09; 95% CI, 1.01-1.17; P = .02) but not diastolic BPV (odds ratio, 1.04; 95% CI, 0.97-1.11; P = .30) or pulse pressure variability (odds ratio, 1.03; 95% CI, 0.96-1.10; P = .47). Survival curves revealed a significant stepwise association between cumulative major adverse cardiovascular events and increasing quartiles of systolic BPV (Kaplan-Meier estimates for quartiles 1-4: 6.1% vs 8.5% vs 10.1% vs 12.0%, respectively; log-rank P <.001). These distinct stepwise associations were not seen with diastolic BPV or pulse pressure variability. CONCLUSIONS AND RELEVANCE: Greater BPV, particularly systolic BPV, is significantly associated with coronary atheroma progression and adverse clinical outcomes. These data suggest maintaining stable blood pressure levels may be important to further improve outcomes in patients with coronary disease.
引用
- Clark D, Nicholls SJ, St John J, et al. Visit-to-Visit Blood Pressure Variability, Coronary Atheroma Progression, and Clinical Outcomes. JAMA Cardiol. 2019. PMID: 30969323. doi:10.1001/jamacardio.2019.0751
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。